€33.85
1.08% today
Xetra, Sep 19, 05:35 pm CET
ISIN
DE0005785604
Symbol
FRE
Sector

Fresenius Stock price

€34.22
+2.14 6.67% 1M
+9.06 36.01% 6M
+6.15 21.91% YTD
+4.10 13.61% 1Y
-6.28 15.50% 3Y
-10.52 23.51% 5Y
-4.51 11.64% 10Y
Xetra, Closing price Wed, Sep 18 2024
-0.22 0.64%
ISIN
DE0005785604
Symbol
FRE
Sector

Key metrics

Market capitalization €19.27b
Enterprise Value €32.27b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 10.26
EV/Sales (TTM) EV/Sales 1.44
P/S ratio (TTM) P/S ratio 0.86
P/B ratio (TTM) P/B ratio 1.01
Dividend yield 2.69%
Last dividend (FY22) €0.92
Revenue growth (TTM) Revenue growth -46.35%
Revenue (TTM) Revenue €22.36b
EBIT (operating result TTM) EBIT €1.35b
Free Cash Flow (TTM) Free Cash Flow €3.14b
Cash position €1.11b
EPS (TTM) EPS €-1.99
P/E forward 20.29
P/S forward 0.88
EV/Sales forward 1.48
Show more

Create a Free Account to create an Fresenius alert.

Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.

Fresenius Stock Analysis

Analyst Opinions

15 Analysts have issued a Fresenius forecast:

12x Buy
80%
3x Hold
20%

Analyst Opinions

15 Analysts have issued a Fresenius forecast:

Buy
80%
Hold
20%

Financial data from Fresenius

Assets
Jun '24
11,943 11,943
Cash 1,108 1,108
Claims 5,236 5,236
Inventories 2,656 2,656
Other current assets Other current assets Current assets 2,943 2,943
31,570 31,570
Property, plant and equipment 9,863 9,863
Financial assets 3,458 3,458
Intangible Assets 17,373 17,373
Other fixed assets Other assets Fixed assets 876 876
Total Assets 43,513 43,513
Liabilities
Jun '24
Equity 19,603 19,603
23,910 23,910
Current liabilities 9,246 9,246
Non-current liabilities 14,664 14,664
Total Capital 43,513 43,513

In millions EUR.

Don't miss a Thing! We will send you all news about Fresenius directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Fresenius Stock News

AD HOC NEWS
7 days ago
Die Aktien von Fresenius DE0005785604 setzen ihre schon länger andauernde Erholungsrally mit Schwung fort.
AD HOC NEWS
7 days ago
Die US-Bank JPMorgan hat Fresenius DE0005785604 von "Neutral" auf "Overweight" hochgestuft und das Kursziel von 37,60 auf 40,10 Euro angehoben.
marktEINBLICKE
3 months ago
Das Gesundheitsunternehmens Fresenius ist zuletzt mit seinem Konzernumbau und den Sparanstrengungen sehr gut vorangekommen.
More Fresenius News

Company Profile

Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products, and services for dialysis, hospitals, and outpatient medical care. It operates through the following segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, Fresenius Vamed, and Corporate and Other. The Fresenius Medical Care segment comprises dialysis products and healthcare services. The Fresenius Kabi segment specializes intravenous drugs, clinical nutrition, infusion therapy, medical devices, and transfusion technology. The Fresenius Helios focuses on the private hospital operations. The Fresenius Vamed segment manages projects and services for hospitals and other healthcare facilities. The Corporate and Other segment includes the holding activities. The company was founded by Eduard Fresenius in October 1912 and is headquartered in Bad Homburg, Germany.

Head office Germany
CEO Michael Sen
Employees 193,865
Founded 1912
Website www.fresenius.de

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today